Author

Chris Daniel

Institutions: University of London, Institute of Structural and Molecular Biology, Birkbeck, University of London

Observed institutions: University of London, Institute of Structural and Molecular Biology, Birkbeck, University of London

ORCID: 0000-0002-8650-516X

Observed ORCID: 0000-0002-8650-516X

OpenAlex ID: A5005452527

Immunobiology of tubercle bacilli and prospects of immunomodulatory drugs to tackle tuberculosis (TB) and other non-tubercular mycobacterial infections

2022 · Chris Daniel, Sanjib Bhakta · Immunobiology · 8

Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays

2024 · Mousumi Shyam, Abhishek Thakur, et al. · Frontiers in Antibiotics · 4

Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics

2023 · Mousumi Shyam, Gourab Bhattacharje, et al. · Molecules · 3

Rapid Gene Silencing Followed by Antimicrobial Susceptibility Testing for Target Validation in Antibiotic Discovery

2024 · Chris Daniel, Sam Willcocks, et al. · Methods in molecular biology · 1

Modified HT-SPOTi: An Antimicrobial Susceptibility Testing to Evaluate Formulated Therapeutic Combinations Against Bacterial Growth and Viability

2024 · Anushandan Navaratnarajah, Chris Daniel, et al. · Methods in molecular biology · 1

Correction to: Rapid Gene Silencing Followed by Antimicrobial Susceptibility Testing for Target Validation in Antibiotic Discovery

2026 · Chris Daniel, Sam Willcocks, et al. · Methods in molecular biology

Development of Carprofen analogues with activity against Mycobacterium tuberculosis

2025 · Liam T. Martin, Chris Daniel, et al. · Bioorganic & Medicinal Chemistry

Works count: 7

Citation count: 17

H-index: 3

I10-index: